Fig. 6From: Mutational landscape of pan-cancer patients with PIK3CA alterations in Chinese populationActionable mutations concomitant with Alpelisib target mutations. A Frequencies of patients harbored actionable co-alterations as defined by OncoKB. B Potential actionable alterations in Alpelisib target co-alterations defined as OncoKB level 1 to 4 in different cancer typesBack to article page